v3.26.1
EQUITY-BASED COMPENSATION
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
EQUITY-BASED COMPENSATION

12. EQUITY-BASED COMPENSATION

 

Restricted Stock Units

 

In December 2025, the Company granted 303,924 restricted stock units to executives of the Company and 104,271 restricted stock units to its board members. These restricted stock units have vesting periods over the next three years.

 

In 2026, the Company granted 12,500 shares restricted stock units to a consultant that vests over 18 months and 12,073 that vest over 4 years.

 

Restricted stock unit activity as of and for the periods below was as follows:

 

   Number of
RSUs
   Weighted
Average
Remaining
Contractual
Term
(Years)
 
Outstanding at December 31, 2025   382,144    1.52 
Granted   24,574    1.50 
Vested or released   (57,321)    
Forfeited        
Outstanding at June 30, 2026   349,397    1.28 

 

The Company recognized approximately $149,000 and $0 in equity-based compensation on restricted stock units for the three months ended June 30, 2026 and 2025, respectively. The Company recognized approximately $297,000 and $0 in equity-based compensation on restricted stock units for the six months ended June 30, 2026 and 2025, respectively.

 

Shares of Restricted Stock

 

In 2025, employees and contractors were granted a total of 76,926 shares of restricted stock. The restricted stock award vested 100% on December 13, 2025.

 

In March 2026, the Company awarded 6,628 shares of restricted stock to a consultant that vested 100% immediately. This consultant also received 15,950 shares of restricted stock in June 2026 that vested 100% immediately.

 

Restricted stock activity as of and for the periods below was as follows:

 

   Number of
RSs
   Weighted
Average
Remaining
Contractual
Term
(Years)
 
Outstanding at December 31, 2025        
Granted   22,578    0.00 
Vested or released   (22,578)    
Forfeited        
Outstanding at June 30, 2026        

 

Total equity-based compensation expense related to shares of restricted stock issuances was approximately $19,000 and $0 for the three months ended June 30, 2026 and 2025, respectively. Total equity-based compensation expense related to shares of restricted stock issuances was approximately $31,000 and $0 for the six months ended June 30, 2026 and 2025, respectively.

 

Stock Options

 

Stock option activity as of and for the periods below was as follows:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
 
Outstanding at December 31, 2025   380   $559.36    6.67 
Granted            
Exercised            
Forfeited            
Outstanding at June 30, 2026   380   $559.36    6.17 
                
Exercisable at June 30, 2026   380   $559.36    6.17 

 

Equity-based compensation expense totaling $0 has been recognized relating to these stock options during the three and six months ended June 30, 2026 and 2025.

  

 

 Warrants

 

Warrant activity as of and for the periods below was as follows:

 

   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
 
Outstanding at December 31, 2025   110,756   $158.35    3.93 
Granted            
Vested or released            
Forfeited            
Outstanding at June 30, 2026   110,756   $158.35    3.43 

 

The Company uses the Black-Scholes option-pricing model to estimate the fair value of equity-based awards. The inputs for the Black-Scholes valuation model require management’s significant assumptions. Prior to the Company’s IPO, the price per share of common stock was determined by the Company’s board based on recent prices of common stock sold in private offerings. Subsequent to the IPO, the price per share of common stock is determined by using the closing market price on the NYSE American on the grant date. The risk-free interest rate is based on the rate for U.S. Treasury securities at the date of grant with maturity dates approximately equal to the expected life at the grant date. The expected term for employee and non-employee awards ranged from 5 to 10 years based on industry data, vesting period, contractual period, among other factors. The expected volatility was estimated based on historical volatility information of the Company. The Company does not expect to pay dividends. For awards with a performance condition, stock compensation is recognized over the requisite service period if it is probable that the performance condition will be satisfied.